![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
.
.
Item in Clipboard
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
.
. Cell Rep. 2021 Sep 7;36(10):109655. doi: 10.1016/j.celrep.2021.109655. Cell Rep. 2021. PMID: 34496253
. Nat Med. 2021 Sep 7. doi: 10.1038/s41591-021-01490-8. Online ahead of print. Nat Med. 2021. PMID: 34493859
